Pharmaceutical Combination cytoprotective, useful in the Prevention and Treatment of systemic inflammatory response syndrome

摘要

The present invention is a combination of pharmacology, with both cellular proteins and immunosuppressants. The peptide in the pharmacological combination is linear lalf 31-52, which increases the immune prevention mechanism, but does not cause increased inflammatory response. The protein in the pharmacological combination is a factor of epidermal growth, which has the effect of cell protein and can effectively transform the signal of cell survival gene. The pharmacological combination of the invention makes system cells and immunoglobulins resistant,To tolerate Dano caused by inflammatory cells and bacterial endocrinology without activating the doomsday pathway of molecules In addition, it reduces the inflammation of the first stage of sepsis and the inflammatory response to infertility injuries, enabling the agency to prevent pathogens from invading, or mediators of incitement, without compromising its integrity.